Mechanisms of enhanced vascular reactivity in preeclampsia

Hypertension

Volumn 58, Issue 5, 2011, Pages 867-873

  Mishra, Nikita ^a,b   Nugent, William H ^a   Mahavadi, Sunila ^b   Walsh, Scott W ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Angiotensin II; Hypertension; Neutrophils; Preeclampsia; Reactive oxygen species; RhoA kinase

Indexed keywords

ANGIOTENSIN II; CATALASE; NORADRENALIN; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SUPEROXIDE DISMUTASE;

ADULT; ARTERY; ARTICLE; BLOOD VESSEL REACTIVITY; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; MYOGRAPHY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; OMENTUM; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADULT; ANGIOTENSIN II; ARTERIES; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; NEUTROPHIL INFILTRATION; NOREPINEPHRINE; OMENTUM; PHOSPHORYLATION; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; RHOA GTP-BINDING PROTEIN; RISK FACTORS; TISSUE CULTURE TECHNIQUES;

EID: 83155180438     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.176602     Document Type: Article

References (46)

1. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III LC, Wenstrom KD. Williams Obstetrics. 22nd ed. New York, NY: McGraw-Hill; 2005.
2. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682-2689.
3. Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol. 1995;22:781-791.
4. Brown MA, Wang J, Whitworth JA. The renin-angiotensin-aldosterone system in pre-eclampsia. Clin Exp Hypertens. 1997;19:713-726. (Pubitemid 27321699)
5. de Jong CL, Dekker GA, Sibai BM. The renin-angiotensin-aldosterone system in preeclampsia: a review. Clin Perinatol. 1991;18:683-711.
6. Pedersen EB, Christensen NJ, Christensen P, Johannesen P, Kornerup HJ, Kristensen S, Lauritsen JG, Leyssac PP, Rasmussen A, Wohlert M. Preeclampsia: a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia. Hypertension. 1983;5:105-111. (Pubitemid 13179796)
7. Leik CE, Walsh SW. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension. 2004;44:72-77. (Pubitemid 38823490)
8. Shah TJ, Walsh SW. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am J Obstet Gynecol. 2007;196:48.e41-48.e48.
9. Lee DL, Webb RC, Jin L. Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension. 2004;44:796-799. (Pubitemid 39577399)
10. Somlyo AP, Somlyo AV. Signal transduction through the RhoA/Rho-kinase pathway in smooth muscle. J Muscle Res Cell Motil. 2004;25:613-615. (Pubitemid 40562022)
11. Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol. 2004;287:H1495-H1500. (Pubitemid 39313251)
12. Jernigan NL, Walker BR, Resta TC. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol. 2008;295:L515-L529.
13. Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 2000;91:21-27.
14. Edwards SW, ed Biochemistry and Physiology of Neutrophil. Melbourne, Australia: Cambridge University Press; 1994.
15. Goldsby RA, Kindt TJ, Osborne BA. Kuby Immunology. 4th ed. New York, NY: WH Freeman and Co; 2000.
16. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 1994;170:1752-1759.
17. Aalkjaer C, Danielsen H, Johannesen P, Pedersen EB, Rasmussen A, Mulvany MJ. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clin Sci (Lond). 1985;69:477-482. (Pubitemid 15003822)
18. Cadden KA, Walsh SW. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertens Pregnancy. 2008;27:396-405.
19. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J, Faas MM. Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril. 2002;77:1032-1037. (Pubitemid 34497175)
20. Lurie S, Frenkel E, Tuvbin Y. Comparison of the differential distribution of leukocytes in preeclampsia versus uncomplicated pregnancy. Gynecol Obstet Invest. 1998;45:229-231. (Pubitemid 28241175)
21. Ducker TP, Skubitz KM. Subcellular localization of CD66, CD67, and NCA in human neutrophils. J Leukoc Biol. 1992;52:11-16.
22. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, II, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA. 1999;282:356-362. (Pubitemid 29350490)
23. Wang YP, Walsh SW, Guo JD, Zhang JY. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol. 1991;165:1695-1700.
24. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33:83-89. (Pubitemid 29061846)
25. Wang JA, Zhen EZ, Guo ZZ, Lu YC. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of antioxidants. Free Radic Biol Med. 1989;7:243-249.
26. Warso MA, Lands WE. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull. 1983;39:277-280. (Pubitemid 13063959)
27. Leeners B, Neumaier-Wagner P, Kuse S, Stiller R, Rath W. Emotional stress and the risk to develop hypertensive diseases in pregnancy. Hypertens Pregnancy. 2007;26:211-226. (Pubitemid 46676547)
28. Klonoff-Cohen HS, Cross JL, Pieper CF. Job stress and preeclampsia. Epidemiology. 1996;7:245-249. (Pubitemid 26120369)
29. Luecken LJ, Suarez EC, Kuhn CM, Barefoot JC, Blumenthal JA, Siegler IC, Williams RB. Stress in employed women: impact of marital status and children at home on neurohormone output and home strain. Psychosom Med. 1997;59:352-359.
30. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Pre-eclampsia: a state of sympathetic overactivity. N Engl J Med. 1996;335: 1480-1485.
31. Belfort MA, Saade GR, Suresh M, Kramer W, Vedernikov YP. Effects of selected vasoconstrictor agonists on isolated omental artery from pre-menopausal nonpregnant women and from normal and preeclamptic pregnant women. Am J Obstet Gynecol. 1996;174:687-693. (Pubitemid 26070166)
32. Walsh SW. Lipid peroxidation in pregnancy. Hypertens Pregn. 1994; 13:1-32. (Pubitemid 24144720)
33. Walsh SW. Maternal-placental interactions of oxidative stress and anti-oxidants in preeclampsia. Semin Reprod Endocrinol. 1998;16:93-104. (Pubitemid 28285307)
34. Walsh SW, Vaughan JE, Wang Y, Roberts LJ II. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000;14:1289-1296. (Pubitemid 30439737)
35. Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V. Activation of leukocytes during the uteroplacental passage in pre-eclampsia. Hypertension. 2002;39:155-160. (Pubitemid 34098104)
36. Estrada-Gutierrez G, Cappello RE, Mishra N, Romero R, Strauss JF III, Walsh SW. Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women a critical mediator of vascular dysfunction. Am J Pathol. 2011;178:451-460.
37. Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in pre-eclampsia: correlation with disease severity. Hypertension. 2010;55: 386-393.
38. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC. AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation. 2003;107:1632-1639. (Pubitemid 36401560)
39. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and Vitamin E in Pregnant Women at Risk for Pre-Eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006;367:1145-1154.
40. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282-1291.
41. Entman SS, Kambam JR, Bradley CA, Cousar JB. Increased levels of carboxyhemoglobin and serum iron as an indicator of increased red cell turnover in preeclampsia. Am J Obstet Gynecol. 1987;156:1169-1173. (Pubitemid 17075469)
42. Entman SS, Richardson LD, Killam AP. Elevated serum ferritin in the altered ferrokinetics of toxemia of pregnancy. Am J Obstet Gynecol. 1982;144:418-422. (Pubitemid 12033910)
43. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791-1798. (Pubitemid 46782996)
44. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402-414.
45. Walsh SW. Eicosanoids in preeclampsia. Prostaglandins Leukot Essent Fatty Acids. 2004;70:223-232. (Pubitemid 38141908)
46. Vaughan JE, Walsh SW, Ford GD. Thromboxane mediates neutrophil superoxide production in pregnancy. Am J Obstet Gynecol. 2006;195: 1415-1420. (Pubitemid 44635359)